New Society for Endocrinology Archive goes back to 1939

Almirall to market Merck Sharp diabetes drug (Reuters, 4 November 2008)

Solvay ends research on obesity treatment compound (Reuters, 17 November 2008)

17 Nov 2008

The Belgian drugs company Solvay, has announced it is ending its research into SLV319, a compound for the treatment of obesity.

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read